ANYSELaboratory Analytical InstrumentsFiscal year ends October 31
AGILENT TECHNOLOGIES, INC.
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 1, 2026
$169.90−3.07 (-1.77%)
Close on Oct 19, 2026
- Market cap
- $48.08B
- P/E (TTM)
- 33.5
- Dividend yield
- 0.58%
AGILENT TECHNOLOGIES, INC. revenue by segment
By business segment
| Revenue | TTM Q3 26 | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Agilent CrossLab | $3.06B | $3.02B | $2.97B | $2.91B | $2.86B | $2.81B | $2.76B | $2.75B | $3.53B | $3.24B | $2.96B | $2.66B | 41.5% | +7.0% |
| Life Sciences and Diagnostics Markets | $2.91B | $2.84B | $2.76B | $2.73B | $2.63B | $2.54B | $2.49B | $2.47B | – | – | – | – | 39.5% | +10.8% |
| Applied Markets | $1.40B | $1.38B | $1.34B | $1.31B | $1.30B | $1.28B | $1.28B | $1.30B | – | – | – | – | 19.0% | +7.8% |
| Diagnostics and Genomics | – | – | – | – | – | – | – | $1.65B | $1.65B | $1.69B | $1.73B | $1.76B | – | – |
| Life Sciences and Applied Markets | – | – | – | – | – | – | – | $3.22B | $3.22B | $3.29B | $3.41B | $3.51B | – | – |
| Operating income | TTM Q3 26 | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Agilent CrossLab | $998.00M | $976.00M | $965.00M | $946.00M | $939.00M | $939.00M | $924.00M | $925.00M | $1.19B | $1.07B | $958.00M | $839.00M | +6.3% |
| Life Sciences and Diagnostics Markets | $618.00M | $560.00M | $528.00M | $536.00M | $505.00M | $501.00M | $487.00M | $484.00M | – | – | – | – | +22.4% |
| Applied Markets | $346.00M | $331.00M | $310.00M | $301.00M | $300.00M | $299.00M | $304.00M | $312.00M | – | – | – | – | +15.3% |
| Diagnostics and Genomics | – | – | – | – | – | – | – | $320.00M | $327.00M | $353.00M | $360.00M | $363.00M | – |
| Life Sciences and Applied Markets | – | – | – | – | – | – | – | $877.00M | $884.00M | $927.00M | $985.00M | $1.05B | – |
By product or service
| Revenue | TTM Q3 26 | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product | $5.24B | $5.14B | $5.02B | $4.94B | $4.83B | $4.72B | $4.66B | $4.67B | $4.69B | $4.79B | $4.94B | $5.05B | 71.1% | +8.4% |
| Non-Instrumentation and Other | $4.80B | $4.70B | $4.61B | $4.52B | $4.39B | $4.28B | $4.18B | $4.16B | $4.11B | $4.12B | $4.12B | $4.09B | 65.1% | +9.2% |
| Instrumentation | $2.57B | $2.53B | $2.46B | $2.43B | $2.39B | $2.35B | $2.35B | $2.35B | $2.39B | $2.47B | $2.61B | $2.74B | 34.9% | +7.4% |
| Services and Other | $2.13B | $2.10B | $2.05B | $2.00B | $1.96B | $1.90B | $1.87B | $1.84B | $1.81B | $1.80B | $1.80B | $1.78B | 28.9% | +9.1% |
By region
| Revenue | TTM Q3 26 | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Americas | $2.98B | $2.90B | $2.82B | $2.81B | $2.71B | $2.65B | $2.61B | $2.57B | $2.60B | $2.64B | $2.68B | $2.73B | 40.4% | +9.9% |
| Asia Pacific | $2.33B | $2.28B | $2.27B | $2.22B | $2.23B | $2.18B | $2.15B | $2.17B | $2.15B | $2.21B | $2.30B | $2.35B | 31.6% | +4.5% |
| Europe | $2.07B | $2.05B | $1.98B | $1.92B | $1.85B | $1.79B | $1.78B | $1.77B | $1.75B | $1.75B | $1.76B | $1.75B | 28.0% | +11.6% |
From the segment and revenue-disaggregation notes of Agilent Technologies's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.